4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-217092
10% owner sold 276,513 shares at an average $40.12 ($11,094,906)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. 10% owner | 2026-05-07 | Sale 10b5-1 | −271,495 | $40.12 | $10,892,651 | 6,437,733 | D |
| Third Rock Ventures V, L.P. 10% owner | 2026-05-08 | Sale 10b5-1 | −5,018 | $40.31 | $202,256 | 6,432,715 | D |
| Open-market sales · 276,513 sh · avg $40.12 · $11,094,906 | |||||||
Loading xslF345X06/ownership.xml…